Cargando…

Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China

SIMPLE SUMMARY: Unselected multigene testing at breast cancer (BC) diagnosis has been reported to be cost-effective compared with family history (FH)/clinical-criteria-based testing in high-income countries such as the US and UK. Chinese patients are younger than Caucasian women at diagnosis, tendin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Li, Cui, Bin, Wei, Xia, Sadique, Zia, Yang, Li, Manchanda, Ranjit, Legood, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997428/ https://www.ncbi.nlm.nih.gov/pubmed/35406611 http://dx.doi.org/10.3390/cancers14071839

Ejemplares similares

Using Genetic Testing at Cancer Diagnosis for Breast Cancer Control
por: Sun, Li, et al.
Publicado: (2022)

Cost–effectiveness of risk-based breast cancer screening programme, China
por: Sun, Li, et al.
Publicado: (2018)

A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
por: Sun, Li, et al.
Publicado: (2019)

Population based germline testing for primary cancer prevention
por: Manchanda, Ranjit, et al.
Publicado: (2018)

Global treatment costs of breast cancer by stage: A systematic review
por: Sun, Li, et al.
Publicado: (2018)

Cost-Effectiveness of Risk-Reducing Surgery for Breast and Ovarian Cancer Prevention: A Systematic Review
por: Wei, Xia, et al.
Publicado: (2022)

Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems
por: Manchanda, Ranjit, et al.
Publicado: (2020)

Cost and logistics of alternative roll-out options for implementing human papillomavirus testing as a triage in cervical screening: results of the sentinel sites study
por: Legood, R, et al.
Publicado: (2012)

Quality of Life after Risk-Reducing Hysterectomy for Endometrial Cancer Prevention: A Systematic Review
por: Oxley, Samuel, et al.
Publicado: (2022)

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing
por: Manchanda, Ranjit, et al.
Publicado: (2014)

Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis
por: Gaba, Faiza, et al.
Publicado: (2023)

Population‐based genetic testing for cancer susceptibility genes: quo vadis?
por: Manchanda, Ranjit, et al.
Publicado: (2022)

Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Pennington, Mark, et al.
Publicado: (2016)

Telemammography for breast cancer screening: a cost-effective approach in Argentina
por: Malek Pascha, Victoria Alba, et al.
Publicado: (2021)

Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews
por: Gaba, Faiza, et al.
Publicado: (2022)

Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study
por: Legood, Rosa, et al.
Publicado: (2012)

Population Based Testing for Primary Prevention: A Systematic Review
por: Manchanda, Ranjit, et al.
Publicado: (2018)

Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study
por: Shi, Ju-Fang, et al.
Publicado: (2011)

Cost-effectiveness of preimplantation genetic testing for aneuploidy for women with subfertility in China: an economic evaluation using evidence from the CESE-PGS trial
por: He, Xuan, et al.
Publicado: (2023)

The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up
por: Maissi, E, et al.
Publicado: (2005)

Special Issue “Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer”
por: Manchanda, Ranjit
Publicado: (2022)

Individual freedom versus collective responsibility: an economic epidemiology perspective
por: Sadique, M Zia
Publicado: (2006)

Is Drotrecogin alfa (activated) for adults with severe sepsis, cost-effective in routine clinical practice?
por: Sadique, M Zia, et al.
Publicado: (2011)

Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes
por: Burnell, Matthew, et al.
Publicado: (2022)

Genetic testing women with newly diagnosed breast cancer: What criteria are the most predictive of a positive test?
por: Metcalfe, Kelly A., et al.
Publicado: (2022)

Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study
por: Devine, Angela, et al.
Publicado: (2021)

Cost Effectiveness of Seasonal Intermittent Preventive Treatment Using Amodiaquine & Artesunate or Sulphadoxine-Pyrimethamine in Ghanaian Children
por: Conteh, Lesong, et al.
Publicado: (2010)

Cost-effectiveness of a cardiac output-guided haemodynamic therapy algorithm in high-risk patients undergoing major gastrointestinal surgery
por: Sadique, Zia, et al.
Publicado: (2015)

Delivering a primary-level non-communicable disease programme for Syrian refugees and the host population in Jordan: a descriptive costing study
por: Ansbro, Éimhín, et al.
Publicado: (2020)

Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study
por: Chandrasekaran, Dhivya, et al.
Publicado: (2021)

How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer
por: Watts, Kaaren J, et al.
Publicado: (2012)

Costs of cervical cancer screening and treatment using visual inspection with acetic acid (VIA) and cryotherapy in Ghana: the importance of scale
por: Quentin, Wilm, et al.
Publicado: (2011)

Systems Medicine of Cancer: Bringing Together Clinical Data and Nonlinear Dynamics of Genetic Networks
por: Blyuss, Konstantin B., et al.
Publicado: (2016)

Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study
por: Gaba, Faiza, et al.
Publicado: (2022)

Management of diabetes and associated costs in a complex humanitarian setting in the Democratic Republic of Congo: a retrospective cohort study
por: Ansbro, Éimhín Mary, et al.
Publicado: (2019)

Women’s Intentions to Engage in Risk-Reducing Behaviours after Receiving Personal Ovarian Cancer Risk Information: An Experimental Survey Study
por: Gallagher, Ailish, et al.
Publicado: (2020)

Association of Angiotensin-Converting Enzyme gene polymorphism in Pakistani women with the atypical steroidogenesis in Polycystic ovarian syndrome: A case-control study
por: Nazeer, Kiran, et al.
Publicado: (2021)

Cost‐effectiveness of alternative changes to a national blood collection service
por: Willis, S., et al.
Publicado: (2018)

Effects of the Learning Together intervention on bullying and aggression in English secondary schools (INCLUSIVE): a cluster randomised controlled trial
por: Bonell, Chris, et al.
Publicado: (2018)

Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients
por: Culver, Julie O., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c727cg2jf64p39l6m25cf269c7